Discovery and characterization of IGFBP-mediated endocytosis in the human retinal pigment epithelial cell line ARPE-19

Experimental Eye Research

Volumn 89, Issue 5, 2009, Pages 629-637

  Ainscough, S Louise ^a,b   Feigl, Beatrix ^a   Malda, Jos ^a   Harkin, Damien G ^a,b  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b QUEENSLAND EYE INSTITUTE   (Australia)

Author keywords

endocytosis; IGF I; IGFBP; phagocytosis; RPE cells; VEGF; vitronectin

Indexed keywords

BOVINE SERUM ALBUMIN; HEPARIN; MICROSPHERE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TRANSFERRIN RECEPTOR; VASCULOTROPIN; VITRONECTIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; PHAGOCYTOSIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN GLYCOSYLATION;

BINDING SITES; BIOLOGICAL TRANSPORT; CELL LINE; ENDOCYTOSIS; EPITHELIAL CELLS; GLYCOSYLATION; HEPARIN; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; KINETICS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MICROSPHERES; PHAGOCYTOSIS; PROTEIN CONFORMATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; RETINAL PIGMENT EPITHELIUM; STRUCTURE-ACTIVITY RELATIONSHIP; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITRONECTIN;

EID: 70349456671     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.06.005     Document Type: Article

References (61)

1. Afzal A., Shaw L.C., Ljubimov A.V., Boulton M.E., Segal M.S., and Grant M.B. Retinal and choroidal microangiopathies: therapeutic opportunities. Microvasc. Res. 74 (2007) 131-144
2. Ainscough S.L., Barnard Z., Upton Z., and Harkin D.G. Vitronectin supports migratory responses of corneal epithelial cells to substrate bound IGF-I and HGF, and facilitates serum-free cultivation. Exp. Eye. Res. 83 (2006) 1505-1514
3. Anderson D.H., Fisher S.K., and Steinberg R.H. Mammalian cones: disc shedding, phagocytosis, and renewal. Invest. Ophthalmol. Vis. Sci. 17 (1978) 117-133
4. Anderson D.H., Hageman G.S., Mullins R.F., Neitz M., Neitz J., Ozaki S., Preissner K.T., and Johnson L.V. Vitronectin gene expression in the adult human retina. Invest. Ophthalmol. Vis. Sci. 40 (1999) 3305-3315
5. Andress D.L. Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells. J. Biol. Chem. 270 (1995) 28289-28296
6. Bok D., and Hall M.O. The role of the pigment epithelium in the etiology of inherited retinal dystrophy in the rat. J. Cell Biol. 49 (1971) 664-682
7. Booth B.A., Boes M., Andress D.L., Dake B.L., Kiefer M.C., Maack C., Linhardt R.J., Bar K., Caldwell E.E., Weiler J., and Bar R.S. IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain. Growth Regul. 5 (1995) 1-17
8. Boyle D., Tien L.F., Cooper N.G., Shepherd V., and McLaughlin B.J. A mannose receptor is involved in retinal phagocytosis. Invest. Ophthalmol. Vis. Sci. 32 (1991) 1464-1470
9. Chan K., and Spencer E.M. Megakaryocytes endocytose insulin-like growth factor (IGF) I and IGF-binding protein-3: a novel mechanism directing them into alpha granules of platelets. Endocrinology 139 (1998) 559-565
10. Chang K.H., Chan-Ling T., McFarland E.L., Afzal A., Pan H., Baxter L.C., Shaw L.C., Caballero S., Sengupta N., Li Calzi S., Sullivan S.M., and Grant M.B. IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development. Proc. Natl. Acad. Sci. U S A 104 (2007) 10595-10600
11. Clemmons D.R. Use of mutagenesis to probe IGF-binding protein structure/function relationships. Endocr. Rev. 22 (2001) 800-817
12. Crabb J.W., Miyagi M., Gu X., Shadrach K., West K.A., Sakaguchi H., Kamei M., Hasan A., Yan L., Rayborn M.E., Salomon R.G., and Hollyfield J.G. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. USA 99 (2002) 14682-14687
13. Davies S., Elliott M.H., Floor E., Truscott T.G., Zareba M., Sarna T., Shamsi F.A., and Boulton M.E. Photocytotoxicity of lipofuscin in human retinal pigment epithelial cells. Free Radic. Biol. Med. 31 (2001) 256-265
14. Dunn K.C., Aotaki-Keen A.E., Putkey F.R., and Hjelmeland L.M. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp. Eye. Res. 62 (1996) 155-169
15. Firth S.M., and Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23 (2002) 824-854
16. Gal A., Li Y., Thompson D.A., Weir J., Orth U., Jacobson S.G., Apfelstedt-Sylla E., and Vollrath D. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat. Genet. 26 (2000) 270-271
17. Gibson A.D., Lamerdin J.A., Zhuang P., Baburaj K., Serpersu E.H., and Peterson C.B. Orientation of heparin-binding sites in native vitronectin. Analyses of ligand binding to the primary glycosaminoglycan-binding site indicate that putative secondary sites are not functional. J. Biol. Chem. 274 (1999) 6432-6442
18. Goda N., Tenno T., Inomata K., Shirakawa M., Tanaka T., and Hiroaki H. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5. Exp. Cell. Res. 314 (2008) 2352-2361
19. Hageman G.S., Mullins R.F., Russell S.R., Johnson L.V., and Anderson D.H. Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. Faseb J. 13 (1999) 477-484
20. Hall M.O., Obin M.S., Heeb M.J., Burgess B.L., and Abrams T.A. Both protein S and Gas6 stimulate outer segment phagocytosis by cultured rat retinal pigment epithelial cells. Exp. Eye. Res. 81 (2005) 581-591
21. Hollier B.G., Kricker J.A., Van Lonkhuyzen D.R., Leavesley D.I., and Upton Z. Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptor. Endocrinology 149 (2008) 1075-1090
22. Hollyfield J.G., and Rayborn M.E. Photoreceptor outer segment development: light and dark regulate the rate of membrane addition and loss. Invest. Ophthalmol. Vis. Sci. 18 (1979) 117-132
23. Hyde C., Hollier B., Anderson A., Harkin D., and Upton Z. Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration. J. Invest. Dermatol. 122 (2004) 1198-1206
24. Irschick E.U., Haas G., Geiger M., Singer W., Ritsch-Marte M., Konwalinka G., Frick M., Gottinger W., and Huemer H.P. Phagocytosis of human retinal pigment epithelial cells: evidence of a diurnal rhythm, involvement of the cytoskeleton and interference of antiviral drugs. Ophthalmic Res. 38 (2006) 164-174
25. Irschick, E.U., Haas, G., Troger, J., Ueberall, F., Huemer, H.P. Involvement of protein kinase C in phagocytosis of human retinal pigment epithelial cells and induction of matrix metalloproteinase secretion, Int. Ophthalmol., in press.
26. Jaques G., Noll K., Wegmann B., Witten S., Kogan E., Radulescu R.T., and Havemann K. Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology 138 (1997) 1767-1770
27. Jones J.I., Prevette T., Gockerman A., and Clemmons D.R. Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc. Natl. Acad. Sci. USA 93 (1996) 2482-2487
28. Kricker J.A., Towne C.L., Firth S.M., Herington A.C., and Upton Z. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin. Endocrinology 144 (2003) 2807-2815
29. Lambooij A.C., van Wely K.H., Lindenbergh-Kortleve D.J., Kuijpers R.W., Kliffen M., and Mooy C.M. Insulin-like growth factor-I and its receptor in neovascular age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2192-2198
30. Leal S.M., Liu Q., Huang S.S., and Huang J.S. The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor. J. Biol. Chem. 272 (1997) 20572-20576
31. Lee K.W., Liu B., Ma L., Li H., Bang P., Koeffler H.P., and Cohen P. Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J. Biol. Chem. 279 (2004) 469-476
32. Lew M. Good statistical practice in pharmacology. Problem 2. Br. J. Pharmacol. 152 (2007) 299-303
33. Li W., Fawcett J., Widmer H.R., Fielder P.J., Rabkin R., and Keller G.A. Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells. Endocrinology 138 (1997) 1763-1766
34. Lofqvist C., Chen J., Connor K.M., Smith A.C., Aderman C.M., Liu N., Pintar J.E., Ludwig T., Hellstrom A., and Smith L.E. IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc. Natl. Acad. Sci. USA 104 (2007) 10589-10594
35. Maile L.A., Busby W.H., Sitko K., Capps B.E., Sergent T., Badley-Clarke J., Ling Y., and Clemmons D.R. The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling. Mol. Endocrinol. 20 (2006) 881-892
36. Mayerson P.L., and Hall M.O. Rat retinal pigment epithelial cells show specificity of phagocytosis in vitro. J. Cell Biol. 103 (1986) 299-308
37. Miceli M.V., Newsome D.A., and Tate Jr. D.J. Vitronectin is responsible for serum-stimulated uptake of rod outer segments by cultured retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 38 (1997) 1588-1597
38. Mochizuki T., Sakai K., and Iwashita M. Effects of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) on endometrial cancer (HHUA) cell apoptosis and EGF stimulated cell proliferation in vitro. Growth Horm. IGF Res. 16 (2006) 202-210
39. Mohseni-Zadeh S., and Binoux M. Insulin-like growth factor (IGF) binding protein-3 interacts with the type 1 IGF receptor, reducing the affinity of the receptor for its ligand: an alternative mechanism in the regulation of IGF action. Endocrinology 138 (1997) 5645-5648
40. Mukherjee P.K., Marcheselli V.L., de Rivero Vaccari J.C., Gordon W.C., Jackson F.E., and Bazan N.G. Photoreceptor outer segment phagocytosis attenuates oxidative stress-induced apoptosis with concomitant neuroprotectin D1 synthesis. Proc. Natl. Acad. Sci. USA 104 (2007) 13158-13163
41. Mukherjee S., and Guidry C. The insulin-like growth factor system modulates retinal pigment epithelial cell tractional force generation. Invest. Ophthalmol. Vis. Sci. 48 (2007) 1892-1899
42. Nandrot E.F., Anand M., Sircar M., and Finnemann S.C. Novel role for alphavbeta5-integrin in retinal adhesion and its diurnal peak. Am. J. Physiol. Cell Physiol. 290 (2006) C1256-C1262
43. Nandrot E.F., Kim Y., Brodie S.E., Huang X., Sheppard D., and Finnemann S.C. Loss of synchronized retinal phagocytosis and age-related blindness in mice lacking alphavbeta5 integrin. J. Exp. Med. 200 (2004) 1539-1545
44. Radulescu R.T. Nuclear localization signal in insulin-like growth factor-binding protein type 3. Trends Biochem. Sci. 19 (1994) 278
45. Rosenthal R., Wohlleben H., Malek G., Schlichting L., Thieme H., Bowes Rickman C., and Strauss O. Insulin-like growth factor-1 contributes to neovascularization in age-related macular degeneration. Biochem. Biophys. Res. Commun. 323 (2004) 1203-1208
46. Schedlich L.J., Graham L.D., O'Han M.K., Muthukaruppan A., Yan X., Firth S.M., and Baxter R.C. Molecular basis of the interaction between IGFBP-3 and retinoid X receptor: role in modulation of RAR-signaling. Arch. Biochem. Biophys. 465 (2007) 359-369
47. Schedlich L.J., Le Page S.L., Firth S.M., Briggs L.J., Jans D.A., and Baxter R.C. Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importing beta subunit. J. Biol. Chem. 275 (2000) 23462-23470
48. Schedlich L.J., Young T.F., Firth S.M., and Baxter R.C. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J. Biol. Chem. 273 (1998) 18347-18352
49. Schvartz I., Seger D., and Shaltiel S. Vitronectin. Int. J. Biochem. Cell Biol. 31 (1999) 539-544
50. Seyfried-Williams R., McLaughlin B.J., and Cooper N.G. Phagocytosis of lectin-coated beads by dystrophic and normal retinal pigment epithelium. Exp. Cell. Res. 154 (1984) 500-509
51. Slomiany M.G., and Rosenzweig S.A. Autocrine effects of IGF-I-induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19. Am. J. Physiol. Cell Physiol. 287 (2004) C746-C753
52. Strauss O. The retinal pigment epithelium in visual function. Physiol. Rev. 85 (2005) 845-881
53. Upton Z., Cuttle L., Noble A., Kempf M., Topping G., Malda J., Xie Y., Mill J., Harkin D.G., Kravchuk O., Leavesley D.I., and Kimble R.M. Vitronectin: growth factor complexes hold potential as a wound therapy approach. J. Invest. Dermatol. 128 (2008) 1535-1544
54. Upton Z., Webb H., Hale K., Yandell C.A., McMurtry J.P., Francis G.L., and Ballard F.J. Identification of vitronectin as a novel insulin-like growth factor-II binding protein. Endocrinology 140 (1999) 2928-2931
55. Van Lonkhuyzen D.R., Hollier B.G., Shooter G.K., Leavesley D.I., and Upton Z. Chimeric vitronectin:insulin-like growth factor proteins enhance cell growth and migration through co-activation of receptors. Growth Factors 25 (2007) 295-308
56. Wilt S.D., Greaton C.J., Lutz D.A., and McLaughlin B.J. Mannose receptor is expressed in normal and dystrophic retinal pigment epithelium. Exp. Eye. Res. 69 (1999) 405-411
57. Wraight C.J., Liepe I.J., White P.J., Hibbs A.R., and Werther G.A. Intranuclear localization of insulin-like growth factor binding protein-3 (IGFBP-3) during cell division in human keratinocytes. J. Invest. Dermatol. 111 (1998) 239-242
58. Yamanaka Y., Fowlkes J.L., Wilson E.M., Rosenfeld R.G., and Oh Y. Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule. Endocrinology 140 (1999) 1319-1328
59. Yang H., and Chaum E. A reassessment of insulin-like growth factor binding protein gene expression in the human retinal pigment epithelium. J. Cell. Biochem. 89 (2003) 933-943
60. Youn H.Y., Bantseev V., Bols N.C., Cullen A.P., and Sivak J.G. In vitro assays for evaluating the ultraviolet B-induced damage in cultured human retinal pigment epithelial cells. J. Photochem. Photobiol. B 88 (2007) 21-28
61. Zheng B., and Clemmons D.R. Blocking ligand occupancy of the alphaVbeta3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA 95 (1998) 11217-11222